Lawrence A. Kenyon files SEC Form 4 disclosures for PAR PHARMACEUTICAL COMPANIES, INC.. They have made 8 open-market trades across 4 companies since 2007, most recently 2026-08-14.
CIK 0001230484
4 open-market purchases totalling $123K since 2007, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OTLK | BUY | 2024-09-26 | 2024-09-30 | $5.69 | $28K | -9.7% | +5.5% | -66.0% |
| OTLK | BUY | 2021-04-20 | 2021-04-20 | $1.83 | $18K | +25.3% | +24.2% | +23.7% |
| OTLK | SELL | 2019-09-18 | 2019-09-23 | $1.70 | $2K | -18.6% | -29.1% | -66.3% |
| OTLK | BUY | 2019-02-07 | 2019-02-08 | $0.90 | $23K | -4.3% | -14.8% | -86.5% |
| ONS | SELL | 2018-09-18 | 2018-09-18 | $0.87 | $9K | +10.1% | +2.2% | N/A |
| ONS | SELL | 2017-12-22 | 2017-12-26 | $1.13 | $30K | +4.1% | +0.8% | -22.1% |
| PRX | SELL | 2010-03-03 | 2010-03-03 | $25.21 | $533K | N/A | N/A | N/A |
| ACEL | BUY | 2007-04-11 | 2007-04-12 | $2.14 | $53K | -0.5% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.